Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue
暂无分享,去创建一个
Hans-Jürgen Thiesen | Johannes P C Vissers | Michael Hecker | Bernd Gerber | M. Glocker | M. Hecker | J. Vissers | T. Reimer | H. Thiesen | B. Gerber | Claudia Röwer | Toralf Reimer | Cornelia Koy | Michael O Glocker | Marc Kipping | C. Koy | C. Röwer | M. Kipping
[1] C. Horak,et al. Clinical-Translational Approaches to the Nm23-H1 Metastasis Suppressor , 2008, Clinical Cancer Research.
[2] M. Gorenstein,et al. Quantitative proteomic analysis by accurate mass retention time pairs. , 2005, Analytical chemistry.
[3] Martin Gilar,et al. Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins. , 2003, Analytical chemistry.
[4] Jens M. Rick,et al. Quantitative mass spectrometry in proteomics: a critical review , 2007, Analytical and bioanalytical chemistry.
[5] C. Vulpe,et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins , 2008, Proteomics.
[6] Elston Cw. Classification and grading of invasive breast carcinoma. , 2005 .
[7] D. Ciocca,et al. A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients , 2007, Cell stress & chaperones.
[8] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[9] Tadashi Kondo,et al. Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE. , 2008, BMB reports.
[10] John W. Tukey,et al. Exploratory Data Analysis. , 1979 .
[11] Menotti Ruvo,et al. Qualitative and quantitative proteomic profiling of cripto(-/-) embryonic stem cells by means of accurate mass LC-MS analysis. , 2009, Journal of proteome research.
[12] E. Perez,et al. Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer. , 2006, The oncologist.
[13] Reinhard Guthke,et al. Rheumatoid arthritis, a complex multifactorial disease: On the way toward individualized medicine , 2006, Medicinal research reviews.
[14] Wilfried Bardet,et al. Identification of breast cancer peptide epitopes presented by HLA-A*0201. , 2008, Journal of proteome research.
[15] Y. Kuramitsu,et al. Proteomic analysis of cancer tissues: Shedding light on carcinogenesis and possible biomarkers , 2006, Proteomics.
[16] Dan Golick,et al. Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures , 2009, Proteomics.
[17] W. Remmele,et al. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. , 1987, Der Pathologe.
[18] Baogang J. Xu,et al. Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS. , 2008, Journal of proteome research.
[19] Tadashi Kondo,et al. The Proteomic Profile of Pancreatic Cancer Cell Lines Corresponding to Carcinogenesis and Metastasis , 2009 .
[20] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[21] Manuel Hidalgo,et al. Intracellular signal transduction pathway proteins as targets for cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] S. Somiari,et al. Proteomics in human cancer research , 2007, Proteomics. Clinical applications.
[23] R. Toillon,et al. Proteomics of breast cancer: the quest for markers and therapeutic targets. , 2008, Journal of proteome research.
[24] Stuart K. Calderwood,et al. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.
[25] Bernhard Schölkopf,et al. Learning with kernels , 2001 .
[26] S. Barni,et al. Targeted therapies for the treatment of breast cancer in the post-trastuzumab era. , 2008, The oncologist.
[27] D. Payne. Desperately Seeking New Antibiotics , 2008, Science.
[28] K. Aoki,et al. Targeted glycoproteomic identification of biomarkers for human breast carcinoma. , 2008, Journal of proteome research.
[29] Ping Wang,et al. Generally detected proteins in comparative proteomics – A matter of cellular stress response? , 2009, Proteomics.
[30] Hailing Lu,et al. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. , 2008, Journal of proteome research.
[31] M. Gorenstein,et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC‐MS/MS , 2009, Proteomics.
[32] M. Glocker,et al. Differential proteome analysis of tonsils from children with chronic tonsillitis or with hyperplasia reveals disease-associated protein expression differences , 2006, Analytical and bioanalytical chemistry.
[33] Feng Chen,et al. Moving cancer diagnostics from bench to bedside. , 2007, Trends in biotechnology.
[34] W. Vach,et al. Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review. , 2008, Journal of proteome research.
[35] Chun-Ming Huang,et al. Breast tumor microenvironment: proteomics highlights the treatments targeting secretome. , 2008, Journal of proteome research.
[36] M. Bantscheff,et al. Proteome Analysis of Diseased Joints from Mice Suffering from Collagen-Induced Arthritis , 2003, Clinical chemistry and laboratory medicine.
[37] E. Winer,et al. New targets for therapy in breast cancer: Small molecule tyrosine kinase inhibitors , 2004, Breast Cancer Research.
[38] Tadashi Kondo,et al. Proteomic signature of human cancer cells , 2004, Proteomics.
[39] T. Reimer,et al. Effectiveness of Trastuzumab (HerceptinTM) in a Patient with Locally Recurrent Breast Cancer after Cardiac Failure Caused by Severe Cytotoxic Pretreatment , 2001, Oncology.
[40] D. Sørensen,et al. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma. , 2008, International journal of oncology.
[41] Johannes P. C. Vissers,et al. Analysis and Quantification of Diagnostic Serum Markers and Protein Signatures for Gaucher Disease*S , 2007, Molecular & Cellular Proteomics.
[42] Patrizia Cancemi,et al. Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non‐tumoral adjacent counterparts , 2007, Proteomics. Clinical applications.
[43] M. Gorenstein,et al. Absolute Quantification of Proteins by LCMSE , 2006, Molecular & Cellular Proteomics.
[44] Keli Ou,et al. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping. , 2008, Journal of proteome research.
[45] I. Jolliffe. Principal Component Analysis , 2002 .
[46] Kerry G Bemis,et al. Label-free mass spectrometry-based protein quantification technologies in proteomic analysis. , 2008, Briefings in functional genomics & proteomics.
[47] L. Alldridge,et al. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. , 2008, Journal of proteome research.
[48] C. Croce. Oncogenes and cancer. , 2008, The New England journal of medicine.